tiprankstipranks
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market
CHGCF
Chugai Pharmaceutical Co
RESEARCH TOOLSreports
Want to see CHGCF full AI Analyst Report?

Chugai Pharmaceutical Co (CHGCF) Ratios

22 Followers

Chugai Pharmaceutical Co Ratios

CHGCF's free cash flow for Q1 2026 was ¥0.71. For the 2026 fiscal year, CHGCF's free cash flow was decreased by ¥ and operating cash flow was ¥0.51. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.70 4.23 5.53 4.74 3.15
Quick Ratio
 3.82 3.56 4.70 3.79 2.46
Cash Ratio
 1.28 1.04 1.86 1.59 0.52
Solvency Ratio
 1.38 1.05 1.37 1.16 0.91
Operating Cash Flow Ratio
 1.36 0.95 1.54 1.42 0.58
Short-Term Operating Cash Flow Coverage
 0.00 0.00 70.32 58.77 37.94
Net Current Asset Value
¥ 1.18T¥ 1.30T¥ 1.30T¥ 1.06T¥ 891.17B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.00 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 0.00 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 0.00 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.19 1.22 1.16 1.19 1.31
Debt Service Coverage Ratio
 510.94 455.73 64.87 50.63 62.51
Interest Coverage Ratio
 631.68 575.24 5.73K 5.07K 8.90K
Debt to Market Cap
 0.00 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
 11.23 0.62 6.68 8.23 8.61
Net Debt to EBITDA
 -0.60 -0.68 -0.92 -0.94 -0.37
Profitability Margins
Gross Profit Margin
71.45%71.09%70.97%62.36%62.15%
EBIT Margin
48.46%47.60%46.40%39.94%42.16%
EBITDA Margin
51.63%50.19%49.10%42.80%44.66%
Operating Profit Margin
47.55%46.92%46.46%37.40%42.38%
Pretax Profit Margin
48.18%47.52%46.39%39.93%42.16%
Net Profit Margin
35.02%34.50%33.09%29.29%29.72%
Continuous Operations Profit Margin
35.02%34.50%33.09%29.29%29.72%
Net Income Per EBT
72.68%72.60%71.32%73.33%70.49%
EBT Per EBIT
101.33%101.29%99.84%106.77%99.48%
Return on Assets (ROA)
19.96%17.58%17.54%16.84%20.03%
Return on Equity (ROE)
23.16%21.42%20.37%20.02%26.29%
Return on Capital Employed (ROCE)
31.69%28.68%28.36%25.28%36.92%
Return on Invested Capital (ROIC)
23.03%20.83%20.16%18.46%25.91%
Return on Tangible Assets
20.49%17.98%17.68%17.02%20.30%
Earnings Yield
3.46%3.20%3.36%3.70%6.76%
Efficiency Ratios
Receivables Turnover
 3.66 2.84 3.50 3.49 2.46
Payables Turnover
 3.43 2.86 21.05 7.71 3.31
Inventory Turnover
 1.28 1.31 1.42 1.53 1.63
Fixed Asset Turnover
 2.68 2.62 2.65 2.64 3.26
Asset Turnover
 0.57 0.51 0.53 0.58 0.67
Working Capital Turnover Ratio
 1.02 0.95 0.98 1.12 1.53
Cash Conversion Cycle
 278.74 278.71 344.71 296.01 261.87
Days of Sales Outstanding
 99.77 128.57 104.22 104.73 148.48
Days of Inventory Outstanding
 285.43 277.85 257.82 238.60 223.65
Days of Payables Outstanding
 106.46 127.71 17.34 47.32 110.26
Operating Cycle
 385.20 406.42 362.05 343.33 372.13
Cash Flow Ratios
Operating Cash Flow Per Share
 270.71 236.65 271.99 249.16 148.41
Free Cash Flow Per Share
 230.08 190.31 241.05 204.03 105.10
CapEx Per Share
 40.63 46.35 30.95 45.14 43.31
Free Cash Flow to Operating Cash Flow
 0.85 0.80 0.89 0.82 0.71
Dividend Paid and CapEx Coverage Ratio
 0.87 1.04 2.43 1.99 1.17
Capital Expenditure Coverage Ratio
 6.66 5.11 8.79 5.52 3.43
Operating Cash Flow Coverage Ratio
 25.45 0.00 41.08 30.47 17.30
Operating Cash Flow to Sales Ratio
 0.35 0.31 0.38 0.37 0.19
Free Cash Flow Yield
2.90%2.31%3.44%3.82%3.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 30.91 31.26 29.74 27.00 14.80
Price-to-Sales (P/S) Ratio
 10.82 10.78 9.84 7.91 4.40
Price-to-Book (P/B) Ratio
 7.33 6.70 6.06 5.41 3.89
Price-to-Free Cash Flow (P/FCF) Ratio
 36.91 43.31 29.04 26.18 32.04
Price-to-Operating Cash Flow Ratio
 31.37 34.83 25.73 21.44 22.69
Price-to-Earnings Growth (PEG) Ratio
 3.02 2.60 1.57 -2.06 0.63
Price-to-Fair Value
 7.33 6.70 6.06 5.41 3.89
Enterprise Value Multiple
 20.36 20.81 19.12 17.54 9.48
Enterprise Value
 12.67T 13.14T 10.99T 8.34T 5.33T
EV to EBITDA
 19.00 20.81 19.12 17.54 9.48
EV to Sales
 9.81 10.44 9.39 7.51 4.23
EV to Free Cash Flow
 33.45 41.95 27.70 24.86 30.84
EV to Operating Cash Flow
 28.43 33.74 24.55 20.35 21.84
Tangible Book Value Per Share
 1.12K 1.20K 1.14K 976.00 850.71
Shareholders’ Equity Per Share
 1.16K 1.23K 1.16K 988.07 866.00
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.29 0.27 0.30
Revenue Per Share
 784.59 764.40 711.34 675.52 766.02
Net Income Per Share
 274.77 263.73 235.36 197.83 227.64
Tax Burden
 0.73 0.73 0.71 0.73 0.70
Interest Burden
 0.99 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.15 0.15 0.15 0.15 0.12
SG&A to Revenue
 0.09 0.09 0.09 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.00 0.00
Income Quality
 0.99 0.90 1.16 1.26 0.42
Currency in JPY